Q2 2024 Holdings
Filed 2024-08-14 | 11 holdings | $135.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $38.8M | 13,275,884 | 28.7% |
| Lexeo Therapeutics(LXEO) | Common Stock | 52886X107 | $37.8M | 2,355,904 | 28.0% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $22.2M | 2,461,319 | 16.4% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $10.2M | 1,076,357 | 7.5% |
| Alumis Inc(ALMS) | Common Stock | 022307102 | $8.7M | 653,225 | 6.4% |
| Morphic Holding | Common Stock | 61775R105 | $5.4M | 159,846 | 4.0% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $4.6M | 843,750 | 3.4% |
| Ikena Oncology | Common Stock | 45175G108 | $3.7M | 2,249,123 | 2.7% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $2.0M | 1,788,160 | 1.5% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $1.3M | 251,270 | 1.0% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $382.6K | 321,502 | 0.3% |